SCIER Author Services

今天，我们来看看这本SCI期刊：JOURNAL OF DRUG TARGETING。从现有的记录来看，JOURNAL OF DRUG TARGETING 的2021年影响因子(JCR2020)是5.121，2020年是3.380，比2020年增长1.741，增长比例51.51%。

关于此刊的具体情况，大家可以看看：

JOURNAL OF DRUG TARGETING 的收稿范围，期刊是如此介绍的(截取部分内容)，详情请阅读：

https://www.tandfonline.com/action/journalInformation?show=aimsScope&journalCode=idrt20

Journal of Drug Targetingpublishes papers and reviews on all aspects of drug delivery and targeting for molecular and macromolecular drugs including the design and characterization of carrier systems (whether colloidal, protein or polymeric) for both vitro and/or in vivo applications of these drugs.

 

Papers are not restricted to drugs delivered by way of a carrier, but also include studies on molecular and macromolecular drugs that are designed to target specific cellular or extra-cellular molecules. As such the journal publishes results on the activity, delivery and targeting of therapeutic peptides/proteins and nucleic acids including genes/plasmid DNA, gene silencing nucleic acids (e.g. small interfering (si)RNA, antisense oligonucleotides, ribozymes, DNAzymes), as well as aptamers, mononucleotides and monoclonal antibodies and their conjugates. The diagnostic application of targeting technologies as well as targeted delivery of diagnostic and imaging agents also fall within the scope of the journal. In addition, papers are sought on self-regulating systems, systems responsive to their environment and to external stimuli and those that can produce programmed, pulsed and otherwise complex delivery patterns.

期刊年发文量

对于 JOURNAL OF DRUG TARGETING 的发文量，2018年发文80多篇，2019年发文150多篇，2020年发文90多篇，2021年发文80篇。

影响因子

即时影响因子计算发现，2022年4月28日，4.592分。按照常规期刊计算方法，以及往年经验，在2022年6月份公布的IF中，它或许在4.5分左右！期待6月份新IF的公布！

有5+分以上发表要求的，来看看这个潜力股的SCI期刊吧！

版权声明：本文转自“51选刊”，文章转载只为学术传播，不代表本号观点，无商业用途，版权归原作者所有，如涉及侵权问题，请联系我们，我们将及时修改或删除。